Health
FDA Authorizes Marketing of First Device that Uses Artificial Intelligence to Help Detect Potential Signs of Colon Cancer – FDA.gov
FDA authorized marketing of the first device that uses artificial intelligence to detect lesions in the colon during a colonoscopy.
For Immediate Release:
April 09, 2021
Today, the U.S. Food and Drug Administration authorized marketing of the GI Genius, the first device that uses artificial intelligence (AI) based on machine learning to assist clinicians in detecting lesions (such as polyps or suspected tumors) in the colon in real time during a colonoscopy.
Artificial intelligence has the potential to transform health care to better assist health care providers and improve patient care. When AI is combined with traditional…
-
General21 hours agoGymnastics club in Berwick shuts down following child safety complaint
-
General15 hours agoAshes engulfed by fresh DRS controversy as TV umpire gives Jamie Smith out despite RTS ‘murmur’
-
General23 hours agoTwo dead after separate road accidents in regional New South Wales
-
Noosa News19 hours agoMeticulously crafted home in heart of Noosa Heads